AQR Arbitrage’s Johnson & Johnson JNJ Stock Holding History

AQR Arbitrage’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,317	Closed	-$830K	–	1189
2020 Q4	$830K	Buy	+5,317	New	+$785K	0.03%	495

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

AQR Arbitrage's JNJ Position: Q1 2021 in Review

AQR Arbitrage sold out of Johnson & Johnson (JNJ) in Q1 2021, closing a stake of 5,317 shares — an estimated $830K sold.

AQR Arbitrage first reported a position in JNJ in Q4 2020 and held it in 1 quarter. The position peaked at $830K in Q4 2020. 3,317 funds tracked by Wall St. Rank hold JNJ as of Q1 2021.

AQR Arbitrage reported no remaining Johnson & Johnson position as of Q1 2021 after selling out during the quarter.
AQR Arbitrage sold 5,317 Johnson & Johnson shares in Q1 2021, an estimated $830K.
AQR Arbitrage first reported a position in Johnson & Johnson in Q4 2020 and held it in 1 quarter.
AQR Arbitrage's Johnson & Johnson position peaked at $830K in Q4 2020.
3,317 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2021.

Based on AQR Arbitrage's 13F filing for Q1 2021, filed 17 May 2021.